Skip to content

Non-surgical Periodontal Therapy during Pregnancy and Risk of Adverse Pregnancy Outcomes

Effect of Non-surgical Periodontal Therapy on Risk of Adverse Pregnancy Outcomes: A Randomized Controlled Trial in Uttarakhand Population. - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/11/076267
Enrollment
75
Registered
2024-11-05
Start date
Unknown
Completion date
Unknown
Last updated
2024-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K056- Periodontal disease, unspecified Health Condition 2: O94- Sequelae of complication of pregnancy, childbirth, and the puerperium

Interventions

Intervention1: Test Group 1 (Non surgical Periodontal Therapy once during pregnancy): Non-surgical periodontal therapy including scaling and polishing will be performed once at gestational age of 16-2

Sponsors

Aaron F Gomes
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: The study population will consist of pregnant women screened from amongst patients who will visit the Department of Periodontology and Oral Implantology, Uttaranchal Dental and Medical Research Institute, Mazri Grant, Dehradun, Uttarakhand, and those who will be presenting for routine antenatal care to the Department of Obstetrics and Gynecology, Uttaranchal Hospital, a unit of Uttarancha Dental and Medical research Institute, Mazri Grant, Dehradun, Uttarakhand. - healthy pregnant women - age 18 to 40 years; - single gestation at =16 weeks; - subjects with at least 20 completely erupted teeth, excluding the third molars; - willing to participate in study

Exclusion criteria

Exclusion criteria: - multiple gestation; - previous preterm low birth weight; - more than 1 previous miscarriage or one greater than 18 weeks; - history of uncontrolled diabetes; hypertension; alcoholism; drug abuse; - history of human immunodeficiency virus (HIV) infection; heart disease, kidney disease or liver disease; recurrent cystitis; viral infections; venereal infections; toxoplasmosis; - history of current use of tobacco (smoking/smokeless) or alcohol;

Design outcomes

Primary

MeasureTime frame
Adverse pregnancy outcome namely low birth weight pre term birth pre term low birth weight pre eclampsia APGAR score Timepoint: 16 weeks to term of the pregnancy

Secondary

MeasureTime frame
Silness and Löe plaque index Löe and Silness Gingival index Lang et al Bleeding on probing index Pocket probing depth clinical attachment levelTimepoint: t1 between 16 to 20 weeks of pregnancy t2 between 21 to 24 weeks of pregnancy t3 between 29 to 32 weeks of pregnancy

Countries

India

Contacts

Public ContactAaron F Gomes

Uttaranchal Dental and Medical Research Institute

aarongomes@hotmail.com9860597402

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026